Clinical Trial Update: A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial update describes a long-term extension study to evaluate the safety and efficacy of Afimkibart (RO7790121) in participants with Atopic Derma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Afimkibart (RO7790121)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING